InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: dr_lowenstein post# 37645

Tuesday, 11/22/2016 4:27:49 PM

Tuesday, November 22, 2016 4:27:49 PM

Post# of 48316
My guess is they are being encouraged by Merck to go ahead with it. PD said their collaborators have been giving them trial design feedback during Analyst day.

It would look embarrassing and SP would take a hit if the FDA rejected a premature application. So I'm sure (hope) they have a good reason behind what they are doing.